Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010;6(1):30–8.

Article  CAS  PubMed  Google Scholar 

Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005;52(9):2936–46.

Article  CAS  PubMed  Google Scholar 

Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol. 2006;177(9):6370–8.

Article  CAS  PubMed  Google Scholar 

Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Investig. 2006;116(8):2262–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qing YF, Zhang QB, Zhou JG, Jiang L. Changes in toll-like receptor (TLR)4-NFkappaB-IL1beta signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis. Rheumatol Int. 2014;34(2):213–20.

Article  CAS  PubMed  Google Scholar 

Harper JL. Out with gout: opening the door on acute inflammation. Immunol Cell Biol. 2010;88(1):13–4.

Article  PubMed  Google Scholar 

Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Therapy. 2010;12(2):206.

Article  Google Scholar 

Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cleophas MC, Crisan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G, Jansen TL, Dinarello CA, Netea MG, Joosten LA. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis. 2016;75(3):593–600.

Article  CAS  PubMed  Google Scholar 

Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, Mietton F, Matteoli G, Hiebert S, Natoli G. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci USA. 2012;109(42):E2865–2874.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziesche E, Kettner-Buhrow D, Weber A, Wittwer T, Jurida L, Soelch J, Muller H, Newel D, Kronich P, Schneider H, et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Res. 2013;41(1):90–109.

Article  CAS  PubMed  Google Scholar 

Mullican SE, Gaddis CA, Alenghat T, Nair MG, Giacomin PR, Everett LJ, Feng D, Steger DJ, Schug J, Artis D, et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 2011;25(23):2480–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265–77.

Article  CAS  PubMed  Google Scholar 

Yang QB, Li LQ, Zhang QB, He YL, Mi QS, Zhou JG. microRNA-223 Deficiency exacerbates Acute Inflammatory response to Monosodium Urate crystals by targeting NLRP3. J Inflamm Res. 2021;14:1845–58.

Article  PubMed  PubMed Central  Google Scholar 

Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S, Rusche JR, Wood MA. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci USA. 2013;110(7):2647–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wells CE, Bhaskara S, Stengel KR, Zhao Y, Sirbu B, Chagot B, Cortez D, Khabele D, Chazin WJ, Cooper A, et al. Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS ONE. 2013;8(7):e68915.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol. 2009;9(10):692–703.

Article  CAS  PubMed  Google Scholar 

Zhu H, Shan L, Schiller PW, Mai A, Peng T. Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation. J Biol Chem. 2010;285(13):9429–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeksema MA, Gijbels MJ, Van den Bossche J, van der Velden S, Sijm A, Neele AE, Seijkens T, Stoger JL, Meiler S, Boshuizen MC, et al. Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med. 2014;6(9):1124–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Garcia S, Malvar Fernandez B, McKinsey TA, Tak PP, Fossati G, et al. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis. 2017;76(1):277–85.

Article  CAS  PubMed  Google Scholar 

Leus NG, van der Wouden PE, van den Bosch T, Hooghiemstra WT, Ourailidou ME, Kistemaker LE, Bischoff R, Gosens R, Haisma HJ, Dekker FJ. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-kappaB p65 transcriptional activity. Biochem Pharmacol. 2016;108:58–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia M, Zhao Q, Zhang H, Chen Y, Yuan Z, Xu Y, Zhang M. Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia. Neural plasticity 2017, 2017:6237351.

Sathishkumar C, Prabu P, Balakumar M, Lenin R, Prabhu D, Anjana RM, Mohan V, Balasubramanyam M. Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes. Clin Epigenetics. 2016;8:125.

Article  PubMed  PubMed Central  Google Scholar 

Martin WJ, Harper JL. Innate inflammation and resolution in acute gout. Immunol Cell Biol. 2010;88(1):15–9.

Article  PubMed  Google Scholar 

Roy S. miRNA in macrophage development and function. Antioxid Redox Signal. 2016;25(15):795–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhanasekar C, Kalaiselvan S, Rasool M. Morin, a Bioflavonoid suppresses Monosodium Urate Crystal-Induced Inflammatory Immune response in RAW 264.7 macrophages through the inhibition of Inflammatory mediators, intracellular ROS levels and NF-kappaB activation. PLoS ONE. 2015;10(12):e0145093.

Article  PubMed  PubMed Central  Google Scholar 

Kelly PN, Romero DL, Yang Y, Shaffer AL 3rd, Chaudhary D, Robinson S, Miao W, Rui L, Westlin WF, Kapeller R, et al. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. J Exp Med. 2015;212(13):2189–201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhuang S. Regulation of STAT signaling by acetylation. Cell Signal. 2013;25(9):1924–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Hsieh MS, Ho HC, Liu YH, Chou DT, Tsai SH. Stimulation of inducible nitric oxide synthase by monosodium urate crystals in macrophages and expression of iNOS in gouty arthritis. Nitric Oxide: Biology Chem. 2004;11(3):228–36.

Article  CAS  Google Scholar 

Tye H, Kennedy CL, Najdovska M, McLeod L, McCormack W, Hughes N, Dev A, Sievert W, Ooi CH, Ishikawa TO, et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell. 2012;22(4):466–78.

Article  CAS  PubMed  Google Scholar 

Yu P, Xiao L, Lin L, Tang L, Chen C, Wang F, Wang Y. STAT3-mediated TLR2/4 pathway upregulation in an IFN-gamma-induced Chlamydia trachomatis persistent infection model. Pathogens Disease 2016, 74(6).

Melkamu T, Kita H, O’Grady SM. TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells. J cell Communication Signal. 2013;7(2):109–18.

Article  Google Scholar 

Mouihate A, Mehdawi H. Toll-like receptor 4-mediated immune stress in pregnant rats activates STAT3 in the fetal brain: role of interleukin-6. Pediatr Res. 2016;79(5):781–7.

Article  CAS  PubMed  Google Scholar 

Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011;3(3):159–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strippoli R, Carvello F, Scianaro R, De Pasquale L, Vivarelli M, Petrini S, Bracci-Laudiero L, De Benedetti F. Amplification of the response to toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum. 2012;64(5):1680–8.

Article  CAS  PubMed  Google Scholar 

Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, De Benedetti F, Strippoli R. IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases. PLoS ONE. 2014;9(10):e107886.